Loading provider…
Loading provider…
Hematology & Oncology Physician in New Port Richey, FL
NPI: 1427285451Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD, PHD Jason's Phone Numberphone_androidMobile
Get MD, PHD Jason's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2011 - 2023

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
USF Health Morsani College of Medicine
health.usf.edu
Medical School
Until 2009
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
Fellowship • Hematology and Medical Oncology
2011 - 2015
University of South Florida Morsani
Residency • Internal Medicine
2009 - 2011
H. Lee Moffitt Cancer Center and Research Institute
Post-Doctoral Fellowship • 2002 - 2005
2002 - 2005
La Jolla Institute for Allergy and Immunology
Post-Doctoral Fellowship • 2000 - 2002
2000 - 2002
A novel NOD-derived murine model of primary Sjögren's syndrome.
Authors: Christopher Robinson
Publication Date: 1998-01
Authors: Kenneth Shain, Rachid Baz, Domenico Coppola, Frederick Locke, Taiga Nishihori, Melissa Alsina, Ciara Freeman, Scott Antonia, Omar Castaneda Puglianini, Bijal Shah, Indumathy Varadarajan, Claudio Anasetti, Jose Ochoa-Bayona
Journal: Clin Cancer Res
Authors: Kenneth Shain, Abhishek Kumar, Rachid Baz, Dae Hyun Lee, Guilherme Oliveira, Ariel Grajales-Cruz, Farhad Khimani, Frederick Locke, Taiga Nishihori, Rawan Faramand, Melissa Alsina, Brandon Blue, Turab Mohammed, Doris Hansen, Hany Elmariah, Hien Liu, Omar Castaneda Puglianini, Sushmita Khadka
Journal: Blood Adv
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Adaptive Biotechnologies
Intervention / Treatment: OTHER: Autologous Stem Cell Transplant, DRUG: Immunomodulatory Agent, DRUG: Proteasome Inhibitor
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Janssen Scientific Affairs, LLC
Intervention / Treatment: DRUG: Dexamethasone Oral, DRUG: Daratumumab Injection, DRUG: Lenalidomide Pill, DRUG: Bortezomib Injection
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: SGN-CD48A